<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mucosally adherent Escherichia coli is frequently observed in intestinal surface of patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, but rarely in healthy control </plain></SENT>
<SENT sid="1" pm="."><plain>Particularly, enteropathogenic Escherichia coli (EPEC) is known to be closely associated with colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> in human </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, one consequence of EPEC <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> in human <z:e sem="disease" ids="C0346627" disease_type="Neoplastic Process" abbrv="">intestinal cancer</z:e> cells was induction of macrophage inhibitory cytokine 1 (MIC-1), which is a multifunctional cytokine with biological activities involved in <z:e sem="disease" ids="C1516170" disease_type="Neoplastic Process" abbrv="">cancer cell growth</z:e>, differentiation and migration </plain></SENT>
<SENT sid="3" pm="."><plain>The present investigation assessed the involvement of MIC-1 protein in EPEC <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>-mediated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell survival </plain></SENT>
<SENT sid="4" pm="."><plain>The challenge with EPEC induced <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell detachment via cytoskeleton rearrangement, which was positively associated with induced MIC-1 expression </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, MIC-1 also mediated RhoA GTPase-linked survival of the detached <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="6" pm="."><plain>Blocking of MIC-1 or RhoA activity increased cellular <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of the detached <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="7" pm="."><plain>In terms of signaling pathway, MIC-1 triggered transforming growth factorÎ²-activated kinase 1 (TAK1), which enhanced expression of RhoA GTPase </plain></SENT>
<SENT sid="8" pm="."><plain>We conclude that EPEC enhances MIC-1 gene expression in the human <z:e sem="disease" ids="C0346627" disease_type="Neoplastic Process" abbrv="">intestinal cancer</z:e> cells, which can be associated with enhanced <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell resistance to anchorage-dependent <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell <z:hpo ids='HP_0011420'>death</z:hpo> via enhanced TAK1 and RhoA GTPase.Oncogene advance online publication, 18 March 2013; doi:10.1038/onc.2012.508 </plain></SENT>
</text></document>